ADMA

Adma Biologics Stock Analysis

AI Rating

Great
  • Quality9/10
  • Growth↑ 9/10
  • Value↑ 5/10
Adma Biologics sales and earnings growth
ADMA Growth
Great
  • Revenue Y/Y↑ 10.74%
  • EPS Y/Y↓ -21.59%
  • FCF Y/Y↑ 19.05%
Adma Biologics gross and profit margin trends
ADMA Profitability
Great
  • Gross margin ↑ 61.30%
  • EPS margin↑ 32.40%
  • ROIC 5Y↑ 22.27%
Adma Biologics net debt vs free cash flow
ADMA Risk
Great
  • Debt / Equity↓ 0.5
  • Debt / FCF↓ 0.6
  • Interest coverage↑ 29.5

Adma Biologics stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks